Literature DB >> 14999091

RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2.

Hongyan Qin1, Jishu Wang, Yingmin Liang, Yoshihito Taniguchi, Kenji Tanigaki, Hua Han.   

Abstract

The DNA-binding protein recombination signal binding protein-Jkappa (RBP-J) mediates transcriptional activation of the Notch intracellular domain (NIC). In the absence of transcriptional activators, RBP-J suppresses transcription by recruiting co-suppressors. KyoT2 is a LIM domain protein that inhibits the RBP-J-mediated transcriptional activation. Here we provide evidence that the polycomb group protein RING1 interacts with the LIM domains of KyoT2 in yeast and mammalian cells. The interaction between KyoT2 and RING1 was detected both in vitro and in vivo. By using a co-immunoprecipitation assay, we also showed that, though RING1 and RBP-J did not associate directly, the two molecules could be co-precipitated simultaneously by KyoT2, probably through the LIM domains and the RBP-J-binding motif of KyoT2, respectively. These results suggested the formation of a three-molecule complex consisting of RBP-J, KyoT2 and RING1 in cells. Moreover, we found that overexpression of RING1 together with KyoT2 in cells inhibited transactivation of RBP-J by NIC. Suppression of the NIC- mediated transactivation of RBP-J by RING1 was abrogated by overexpression of KBP1, a molecule that competed with RING1 for binding to LIM domains of KyoT2, suggesting that suppression of RBP-J by RING1 was dependent on its associating with KyoT2. Taken together, our data suggested that there might be at least two ways of the KyoT2-mediated suppression of RBP-J, namely competition for binding sites with transactivators, and recruitment of suppressors such as RING1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999091      PMCID: PMC390284          DOI: 10.1093/nar/gkh295

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.

Authors:  Franz Oswald; Ulrike Kostezka; Kathy Astrahantseff; Soizic Bourteele; Karin Dillinger; Ulrich Zechner; Leopold Ludwig; Monika Wilda; Horst Hameister; Walter Knöchel; Susanne Liptay; Roland M Schmid
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

2.  The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor.

Authors:  S Dou; X Zeng; P Cortes; H Erdjument-Bromage; P Tempst; T Honjo; L D Vales
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

3.  The LIM/double zinc-finger motif functions as a protein dimerization domain.

Authors:  R Feuerstein; X Wang; D Song; N E Cooke; S A Liebhaber
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 4.  The LIM domain: a new structural motif found in zinc-finger-like proteins.

Authors:  I Sánchez-García; T H Rabbitts
Journal:  Trends Genet       Date:  1994-09       Impact factor: 11.639

5.  Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates.

Authors:  F Schweisguth; J W Posakony
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

6.  Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway.

Authors:  Kazuki Kuroda; Hua Han; Shoichi Tani; Kenji Tanigaki; Tin Tun; Takahisa Furukawa; Yoshihito Taniguchi; Hisanori Kurooka; Yoshio Hamada; Shinya Toyokuni; Tasuku Honjo
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

7.  Notch1 is essential for postimplantation development in mice.

Authors:  P J Swiatek; C E Lindsell; F F del Amo; G Weinmaster; T Gridley
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

8.  Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Authors:  T Henkel; P D Ling; S D Hayward; M G Peterson
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

9.  The LIM domain is a modular protein-binding interface.

Authors:  K L Schmeichel; M C Beckerle
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

10.  The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

Authors:  L Waltzer; F Logeat; C Brou; A Israel; A Sergeant; E Manet
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  19 in total

1.  [Inhibitory effect of KyoT2 overexpression on proliferation and migration of airway smooth muscle cells in mice with asthma].

Authors:  Long Zhao; Cui-Cui Liu; Xiao-Lan Shi; Ning Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

2.  Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.

Authors:  Yiqun Zhou; Chunhua Wan; Yifei Liu; Liting Lv; Buyou Chen; Runzhou Ni; Yuexia Huang; Yangcheng Li; Xiaodong Zheng; Dunpeng Yang; Guoxin Mao; Qun Xue
Journal:  Pathol Oncol Res       Date:  2014-01-11       Impact factor: 3.201

Review 3.  The role of Notch receptors in transcriptional regulation.

Authors:  Hongfang Wang; Chongzhi Zang; X Shirley Liu; Jon C Aster
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

4.  The Spen homolog Msx2-interacting nuclear target protein interacts with the E2 ubiquitin-conjugating enzyme UbcH8.

Authors:  Junfeng Li; Jishu Wang; Xi Yang; Junlin Li; Hongyan Qin; Xiao Dong; Yangting Zhu; Liang Liang; Yingmin Liang; Hua Han
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

5.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

Review 6.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

7.  Structure and function of the CSL-KyoT2 corepressor complex: a negative regulator of Notch signaling.

Authors:  Kelly J Collins; Zhenyu Yuan; Rhett A Kovall
Journal:  Structure       Date:  2013-11-27       Impact factor: 5.006

8.  Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.

Authors:  Joachim Schessl; Yaqun Zou; Meagan J McGrath; Belinda S Cowling; Baijayanta Maiti; Steven S Chin; Caroline Sewry; Roberta Battini; Ying Hu; Denny L Cottle; Michael Rosenblatt; Lynn Spruce; Arupa Ganguly; Janbernd Kirschner; Alexander R Judkins; Jeffrey A Golden; Hans-Hilmar Goebel; Francesco Muntoni; Kevin M Flanigan; Christina A Mitchell; Carsten G Bönnemann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis.

Authors:  Denny L Cottle; Meagan J McGrath; Brendan R Wilding; Belinda S Cowling; Jordan M Kane; Colleen E D'Arcy; Melissa Holdsworth; Irene Hatzinisiriou; Mark Prescott; Susan Brown; Christina A Mitchell
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

10.  Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms.

Authors:  Hai-Feng Ou-Yang; Hong-Wei Zhang; Chang-Gui Wu; Ping Zhang; Jian Zhang; Jun-Chang Li; Li-Hong Hou; Fei He; Xin-Yu Ti; Li-Qiang Song; Su-Zhen Zhang; Lei Feng; Hao-Wen Qi; Hua Han
Journal:  Mol Cell Biochem       Date:  2008-09-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.